"PUL provides reference testing services to hospitals, clinics and is the largest reference lab in Beijing," said Dr. Ho. "We are pleased to use our experience across numerous lab platforms to support PPD's global central labs."
The PUL global central lab participates in the College of American Pathologists (CAP) external proficiency testing program and has applied for CAP accreditation. PUL is performing National Glycohemoglobin Standards Program testing in anticipation of accreditation.
This year marks PPD's 20th anniversary providing global central lab services.
PPD is a leading global contract research organization providing discovery, development and post-approval services as well as compound partnering programs. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 30 countries and more than 10,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help its clients and partners maximize returns on their R&D investments and accelerate the delivery of safe and effective therapeutics to patients. For more information, visit our Web site at http://www.ppdi.com.
Except for historical information, all of the statements, expectations
and assumptions contained in this news release, including expectations and
assumptions about the expansion of PPD global central lab services, are
forward-looking statements that involve a number of risks and
uncertainties. Although PPD attempts to be accurate in making these
forward-looking statements, it is possible that future circumstances might
differ from the assumptions on which such statements are based. In
addition, other important factors which could cause results to differ
materially include the following: ris
|SOURCE PPD, Inc.|
Copyright©2008 PR Newswire.
All rights reserved